E-selectin ligand binding affinity to determine anti-metastatic efficacy of proteasome inhibition.

被引：1
|
作者：
Lange, Tobias
Valentiner, Ursula
Wicklein, Daniel
Maar, Hanna
Labitzky, Vera
Brauns, Ann-Kristin
Streichert, Thomas
Otto, Benjamin
Sauter, Guido
Wolters-Eisfeld, Gerrit
Riecken, Kristoffer
Arnchen, Christian Ba
Kiefmann, Rainer
Abraham, Valsamma
DeLisser, Horace M.
Gemoll, Timo
Habermann, Jens K.
Schumacher, Udo
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e23010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23010
引用
收藏
页数：2
相关论文
共 46 条
  • [31] Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform
    Casazza, Andrea
    Kigel, Boaz
    Maione, Federica
    Capparuccia, Lorena
    Kessler, Ofra
    Giraudo, Enrico
    Mazzone, Massimiliano
    Neufeld, Gera
    Tamagnone, Luca
    EMBO MOLECULAR MEDICINE, 2012, 4 (03) : 234 - 250
  • [32] Myeloma cell binding and proliferation to bone marrow endothelial cells is mediated through E-selectin/ESL-1 ligand pair.
    Kripas, C
    Monroe, J
    Bergsagel, L
    Lo, S
    Moore, MAS
    Silverstein, R
    Rafii, S
    BLOOD, 1997, 90 (10) : 1571 - 1571
  • [33] THE ELAM LIGAND FUCOSYL-TRANSFERASE, ELFT, DIRECTS E-SELECTIN BINDING TO A SECRETED SCAFFOLD PROTEIN - A METHOD TO PRODUCE AND PURIFY LARGE QUANTITIES OF SPECIFIC CARBOHYDRATE STRUCTURES
    MEIER, W
    LEONE, DR
    MIATKOWSKI, K
    LOBB, R
    GOELZ, SE
    BIOCHEMICAL JOURNAL, 1993, 294 : 25 - 30
  • [34] Leukocyte E-Selectin ligand, PSGL-1, is expressed on human bone-metastatic prostate tumor cells and mediates rolling interactions on human bone marrow endothelium
    不详
    CLINICAL & EXPERIMENTAL METASTASIS, 2004, 21 (07) : 599 - 600
  • [35] Quantitative Characterization of E-selectin Interaction with Native CD44 and P-selectin Glycoprotein Ligand-1 (PSGL-1) Using a Real Time Immunoprecipitation-based Binding Assay
    AbuSamra, Dina B.
    Al-Kilani, Alia
    Hamdan, Samir M.
    Sakashita, Kosuke
    Gadhoum, Samah Z.
    Merzaban, Jasmeen S.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (35) : 21213 - 21230
  • [36] Inhibition of fucosylation in human invasive ductal carcinoma reduces E-selectin ligand expression, cell proliferation, and ERK1/2 and p38 MAPK activation
    Carrascal, Mylene A.
    Silva, Mariana
    Ramalho, Jose S.
    Pen, Claudia
    Martins, Manuela
    Pascoal, Carlota
    Amaral, Constanca
    Serrano, Isabel
    Oliveira, Maria Jose
    Sackstein, Robert
    Videira, Paula A.
    MOLECULAR ONCOLOGY, 2018, 12 (05) : 579 - 593
  • [37] Novel Anti-Metastatic Action of Cidofovir Mediated by Inhibition of E6/E7, CXCR4 and Rho/ROCK Signaling in HPV+ Tumor Cells
    Amine, Abdessamad
    Rivera, Sofia
    Opolon, Paule
    Dekkal, Mehdi
    Biard, Denis S. F.
    Bouamar, Hakim
    Louache, Fawzia
    McKay, Michael J.
    Bourhis, Jean
    Deutsch, Eric
    Vozenin-Brotons, Marie-Catherine
    PLOS ONE, 2009, 4 (03):
  • [38] Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth
    Festuccia, Claudio
    Mancini, Andrea
    Gravina, Giovanni Luca
    Colapietro, Alessandro
    Vetuschi, Antonella
    Pompili, Simona
    Ventura, Luca
    Delle Monache, Simona
    Iorio, Roberto
    Del Fattore, Andrea
    Fogler, William
    Magnani, John
    CELLS, 2020, 9 (01)
  • [39] Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial
    Wamil, BD
    Thurman, GB
    Sundell, HW
    DeVore, RF
    Wakefield, G
    Johnson, DH
    Wang, YF
    Hellerqvist, CG
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1997, 123 (03) : 173 - 179
  • [40] Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial
    Barbara D. Wamil
    Gary B. Thurman
    Hakan W. Sundell
    Russel F. DeVore
    Gail Wakefield
    David H. Johnson
    Yue-Fen Wang
    Carl G. Hellerqvist
    Journal of Cancer Research and Clinical Oncology, 1997, 123 (3) : 173 - 179
12345